National Medical Care Co. (Care) reported a net profit after Zakat and tax of SAR 30 million in Q1 2022, a 16% decline from SAR 35.7 million in the previous year.
Item | Q1 2021 | Q1 2022 | Change |
---|---|---|---|
Revenues | 214.19 | 211.48 | (1.3 %) |
Gross Income | 63.64 | 61.44 | (3.5 %) |
Operating Income | 42.18 | 35.17 | (16.6 %) |
Net Income | 35.73 | 30.00 | (16.0 %) |
Average Shares | 44.85 | 44.85 | - |
EPS (Riyals) | 0.80 | 0.67 | (16.0 %) |
Item | Q4 2021 | Q1 2022 | Change |
---|---|---|---|
Revenues | 215.59 | 211.48 | (1.9 %) |
Gross Income | 61.98 | 61.44 | (0.9 %) |
Operating Income | 36.65 | 35.17 | (4.0 %) |
Net Income | 36.71 | 30.00 | (18.3 %) |
Average Shares | 44.85 | 44.85 | - |
EPS (Riyals) | 0.82 | 0.67 | (18.3 %) |
The lower earnings were attributed to a 1.3 fall year-on-year (YoY) in net revenue due to reduced referrals from the Ministry of Health (MoH) and General Organization for Social Insurance (GOSI). Gross profit margin declined to 29.1% YoY on a reduction in higher-margin business from MoH and GOSI.
Additionally, selling and marketing expenses, and general and administrative expenses surged.
Sequentially, net profit after Zakat and tax declined 18.3% from SAR 36.71 million in Q4 2021.
Total shareholders’ equity, excluding minority interest, rose 7.6% to SAR 1.154 billion in Q1 2022, compared to SAR 1.072 billion in the year-ago period.
Period | Revenues | Change | Gross Income | Change | Net Income | Change | EPS(Riyal) |
---|---|---|---|---|---|---|---|
Q1 2013 | 145.36 | 12.8 % | 38.75 | 9.0 % | 31.12 | 7.8 % | 0.69 |
Q2 2013 | 142.20 | 3.6 % | 31.78 | (15.5 %) | 22.19 | (25.0 %) | 0.49 |
Q3 2013 | 134.56 | 11.2 % | 24.08 | (19.9 %) | 18.80 | (12.4 %) | 0.42 |
Q4 2013 | 164.16 | 19.3 % | 33.54 | 5.0 % | 20.39 | (18.6 %) | 0.45 |
2013 | 586.28 | 11.7 % | 130.06 | (3.8 %) | 92.50 | (11.9 %) | 2.06 |
Q1 2014 | 181.82 | 25.1 % | 42.99 | 10.9 % | 32.40 | 4.1 % | 0.72 |
Q2 2014 | 179.74 | 26.4 % | 56.27 | 77.0 % | 31.06 | 40.0 % | 0.69 |
Q3 2014 | 177.44 | 31.9 % | 40.16 | 66.8 % | 20.76 | 10.4 % | 0.46 |
Q4 2014 | 194.99 | 18.8 % | 37.85 | 12.9 % | 10.28 | (49.6 %) | 0.23 |
2014 | 733.99 | 25.2 % | 177.27 | 36.3 % | 95.46 | 3.2 % | 2.13 |
Q1 2015 | 219.43 | 20.7 % | 54.12 | 25.9 % | 27.72 | (14.4 %) | 0.62 |
Q2 2015 | 227.86 | 26.8 % | 64.96 | 15.4 % | 42.29 | 36.1 % | 0.94 |
Q3 2015 | 210.78 | 18.8 % | 50.78 | 26.5 % | 25.47 | 22.7 % | 0.57 |
Q4 2015 | 220.60 | 13.1 % | 50.34 | 33.0 % | 35.24 | 242.7 % | 0.79 |
2015 | 878.67 | 19.7 % | 220.20 | 24.2 % | 130.72 | 36.9 % | 2.91 |
Q1 2016 | 253.94 | 15.7 % | 67.29 | 24.3 % | 33.12 | 19.5 % | 0.74 |
Q2 2016 | 259.77 | 14.0 % | 84.30 | 29.8 % | 59.29 | 40.2 % | 1.32 |
Q3 2016 | 197.01 | (6.5 %) | 50.54 | (0.5 %) | 27.55 | 8.2 % | 0.61 |
Q4 2016 | 189.94 | (13.9 %) | 4.86 | (90.3 %) | (69.69) | (297.8 %) | (1.55) |
2016 | 900.65 | 2.5 % | 206.99 | (6.0 %) | 50.27 | (61.5 %) | 1.12 |
Q1 2017 | 202.44 | (20.3 %) | 41.19 | (38.8 %) | 15.54 | (53.1 %) | 0.35 |
Q2 2017 | 216.54 | (16.6 %) | 50.25 | (40.4 %) | 19.50 | (67.1 %) | 0.43 |
Q3 2017 | 208.34 | 5.8 % | 46.97 | (7.1 %) | 27.00 | (2.0 %) | 0.60 |
Q4 2017 | 227.76 | 19.9 % | 57.00 | 1072.0 % | 23.26 | 133.4 % | 0.52 |
2017 | 855.08 | (5.1 %) | 195.40 | (5.6 %) | 85.30 | 69.7 % | 1.90 |
Q1 2018 | 206.67 | 2.1 % | 51.73 | 25.6 % | 25.60 | 64.8 % | 0.57 |
Q2 2018 | 199.05 | (8.1 %) | 49.59 | (1.3 %) | 20.26 | 3.9 % | 0.45 |
Q3 2018 | 176.40 | (15.3 %) | 33.17 | (29.4 %) | 11.44 | (57.6 %) | 0.26 |
Q4 2018 | 181.69 | (20.2 %) | 32.02 | (43.8 %) | 4.87 | (79.1 %) | 0.11 |
2018 | 763.80 | (10.7 %) | 166.51 | (14.8 %) | 62.18 | (27.1 %) | 1.39 |
Q1 2019 | 179.43 | (13.2 %) | 48.01 | (7.2 %) | 29.99 | 17.1 % | 0.67 |
Q2 2019 | 169.94 | (14.6 %) | 38.26 | (22.8 %) | 13.81 | (31.8 %) | 0.31 |
Q3 2019 | 173.51 | (1.6 %) | 40.11 | 20.9 % | 16.64 | 45.4 % | 0.37 |
Q4 2019 | 185.52 | 2.1 % | 39.27 | 22.6 % | 19.64 | 303.2 % | 0.44 |
2019 | 708.39 | (7.3 %) | 165.66 | (0.5 %) | 80.09 | 28.8 % | 1.79 |
Q1 2020 | 195.02 | 8.7 % | 52.22 | 8.8 % | 33.17 | 10.6 % | 0.74 |
Q2 2020 | 186.04 | 9.5 % | 58.87 | 53.9 % | 25.78 | 86.6 % | 0.57 |
Q3 2020 | 213.31 | 22.9 % | 51.06 | 27.3 % | 16.32 | (1.9 %) | 0.36 |
Q4 2020 | 214.60 | 15.7 % | 61.73 | 57.2 % | 22.00 | 12.0 % | 0.49 |
2020 | 808.95 | 14.2 % | 223.88 | 35.1 % | 97.27 | 21.4 % | 2.17 |
Q1 2021 | 214.19 | 9.8 % | 63.64 | 21.9 % | 35.73 | 7.7 % | 0.80 |
Q2 2021 | 202.49 | 8.8 % | 57.77 | (1.9 %) | 30.74 | 19.2 % | 0.69 |
Q3 2021 | 213.11 | (0.1 %) | 63.08 | 23.5 % | 33.17 | 103.2 % | 0.74 |
Q4 2021 | 215.59 | 0.5 % | 61.98 | 0.4 % | 36.71 | 66.9 % | 0.82 |
2021 | 845.38 | 4.5 % | 246.47 | 10.1 % | 136.36 | 40.2 % | 3.04 |
Q1 2022 | 211.48 | (1.3 %) | 61.44 | (3.5 %) | 30.00 | (16.0 %) | 0.67 |
Period | Revenues | Change | Gross Income | Change | Net Income | Change | EPS(Riyal) |
---|---|---|---|---|---|---|---|
2012 | 524.75 | 14.5 % | 135.13 | 11.4 % | 104.96 | 10.8 % | 2.34 |
2013 | 586.28 | 11.7 % | 130.06 | (3.8 %) | 92.50 | (11.9 %) | 2.06 |
2014 | 733.99 | 25.2 % | 177.27 | 36.3 % | 95.46 | 3.2 % | 2.13 |
2015 | 878.67 | 19.7 % | 220.20 | 24.2 % | 130.72 | 36.9 % | 2.91 |
2016 | 900.65 | 2.5 % | 206.99 | (6.0 %) | 50.27 | (61.5 %) | 1.12 |
2017 | 855.08 | (5.1 %) | 195.40 | (5.6 %) | 85.30 | 69.7 % | 1.90 |
2018 | 763.80 | (10.7 %) | 166.51 | (14.8 %) | 62.18 | (27.1 %) | 1.39 |
2019 | 708.39 | (7.3 %) | 165.66 | (0.5 %) | 80.09 | 28.8 % | 1.79 |
2020 | 808.95 | 14.2 % | 223.88 | 35.1 % | 97.27 | 21.4 % | 2.17 |
2021 | 845.38 | 4.5 % | 246.47 | 10.1 % | 136.36 | 40.2 % | 3.04 |
Period | Gross Margin | OIBDA Margin | Net Margin Before Unusual Items |
---|---|---|---|
Q1 2013 | 25.56 % | 24.89 % | 19.81 % |
Q2 2013 | 24.27 % | 23.17 % | 18.27 % |
Q3 2013 | 22.61 % | 21.99 % | 17.36 % |
Q4 2013 | 21.86 % | 20.98 % | 15.78 % |
2013 | 22.18 % | 20.98 % | 15.78 % |
Q1 2014 | 21.26 % | 20.31 % | 15.06 % |
Q2 2014 | 23.76 % | 21.17 % | 15.55 % |
Q3 2014 | 24.60 % | 20.97 % | 14.88 % |
Q4 2014 | 24.15 % | 19.46 % | 12.88 % |
2014 | 24.15 % | 19.59 % | 13.01 % |
Q1 2015 | 24.42 % | 18.66 % | 11.64 % |
Q2 2015 | 24.04 % | 18.90 % | 12.33 % |
Q3 2015 | 24.35 % | 19.23 % | 12.40 % |
Q4 2015 | 25.06 % | 21.32 % | 14.88 % |
2015 | 25.06 % | 21.32 % | 14.88 % |
Q1 2016 | 25.56 % | 21.44 % | 14.91 % |
Q2 2016 | 26.74 % | 23.27 % | 16.20 % |
Q3 2016 | 27.11 % | 23.91 % | 16.67 % |
Q4 2016 | 22.98 % | 16.07 % | 9.33 % |
2016 | 22.98 % | 17.75 % | 9.33 % |
Q1 2017 | 21.30 % | 14.58 % | 7.82 % |
Q2 2017 | 18.22 % | 10.27 % | 3.31 % |
Q3 2017 | 17.53 % | 9.96 % | 3.19 % |
Q4 2017 | 22.85 % | 18.52 % | 10.12 % |
2017 | 22.85 % | 18.52 % | 10.12 % |
Q1 2018 | 23.97 % | 20.17 % | 11.24 % |
Q2 2018 | 24.39 % | 20.91 % | 11.57 % |
Q3 2018 | 23.64 % | 20.41 % | 10.10 % |
Q4 2018 | 21.80 % | 20.00 % | 8.14 % |
2018 | 21.80 % | 20.00 % | 8.14 % |
Q1 2019 | 22.10 % | 21.08 % | 9.04 % |
Q2 2019 | 21.41 % | 21.09 % | 8.50 % |
Q3 2019 | 22.48 % | 21.77 % | 9.27 % |
Q4 2019 | 23.38 % | 22.17 % | 11.31 % |
2019 | 23.38 % | 22.17 % | 11.31 % |
Q1 2020 | 23.46 % | 22.32 % | 11.50 % |
Q2 2020 | 25.74 % | 23.29 % | 12.87 % |
Q3 2020 | 25.83 % | 22.00 % | 12.17 % |
Q4 2020 | 27.68 % | 21.05 % | 12.02 % |
2020 | 27.68 % | 21.05 % | 12.02 % |
Q1 2021 | 28.41 % | 20.86 % | 12.06 % |
Q2 2021 | 27.73 % | 21.19 % | 12.41 % |
Q3 2021 | 29.16 % | 23.15 % | 14.41 % |
Q4 2021 | 29.15 % | 24.41 % | 16.13 % |
2021 | 29.15 % | 24.41 % | 16.13 % |
Q1 2022 | 28.99 % | 23.58 % | 15.50 % |
Period | Gross Margin | OIBDA Margin | Net Margin Before Unusual Items |
---|---|---|---|
2012 | 25.75 % | 25.14 % | 20.00 % |
2013 | 22.18 % | 20.98 % | 15.78 % |
2014 | 24.15 % | 19.59 % | 13.01 % |
2015 | 25.06 % | 21.32 % | 14.88 % |
2016 | 22.98 % | 17.75 % | 9.33 % |
2017 | 22.85 % | 18.52 % | 10.12 % |
2018 | 21.80 % | 20.00 % | 8.14 % |
2019 | 23.38 % | 22.17 % | 11.31 % |
2020 | 27.68 % | 21.05 % | 12.02 % |
2021 | 29.15 % | 24.41 % | 16.13 % |
Period | Gross Margin | OIBDA Margin | Net Margin Before Unusual Items |
---|---|---|---|
Q1 2013 | 26.65 % | 26.37 % | 21.41 % |
Q2 2013 | 22.35 % | 20.42 % | 15.60 % |
Q3 2013 | 17.89 % | 18.61 % | 13.97 % |
Q4 2013 | 20.43 % | 18.63 % | 12.42 % |
Q1 2014 | 23.64 % | 22.99 % | 17.82 % |
Q2 2014 | 31.31 % | 23.55 % | 17.28 % |
Q3 2014 | 22.63 % | 18.45 % | 11.70 % |
Q4 2014 | 19.41 % | 13.33 % | 5.27 % |
Q1 2015 | 24.67 % | 19.55 % | 12.63 % |
Q2 2015 | 28.51 % | 23.38 % | 18.56 % |
Q3 2015 | 24.09 % | 19.85 % | 12.09 % |
Q4 2015 | 22.82 % | 22.37 % | 15.97 % |
Q1 2016 | 26.50 % | 20.19 % | 13.04 % |
Q2 2016 | 32.45 % | 29.83 % | 22.83 % |
Q3 2016 | 25.65 % | 22.64 % | 13.99 % |
Q4 2016 | 2.56 % | (15.05 %) | (18.93 %) |
Q1 2017 | 20.35 % | 15.00 % | 7.68 % |
Q2 2017 | 23.20 % | 16.81 % | 9.01 % |
Q3 2017 | 22.54 % | 20.74 % | 12.96 % |
Q4 2017 | 25.02 % | 21.25 % | 10.76 % |
Q1 2018 | 25.03 % | 21.90 % | 12.39 % |
Q2 2018 | 24.91 % | 19.67 % | 10.18 % |
Q3 2018 | 18.81 % | 18.43 % | 6.49 % |
Q4 2018 | 17.62 % | 19.73 % | 2.68 % |
Q1 2019 | 26.76 % | 26.61 % | 16.71 % |
Q2 2019 | 22.51 % | 19.46 % | 8.13 % |
Q3 2019 | 23.12 % | 21.16 % | 9.59 % |
Q4 2019 | 21.17 % | 21.29 % | 10.59 % |
Q1 2020 | 26.78 % | 26.82 % | 17.01 % |
Q2 2020 | 31.64 % | 23.57 % | 13.86 % |
Q3 2020 | 23.94 % | 16.85 % | 7.65 % |
Q4 2020 | 28.77 % | 17.82 % | 10.25 % |
Q1 2021 | 29.71 % | 25.54 % | 16.68 % |
Q2 2021 | 28.53 % | 24.72 % | 15.18 % |
Q3 2021 | 29.60 % | 24.62 % | 15.57 % |
Q4 2021 | 28.75 % | 22.79 % | 17.03 % |
Q1 2022 | 29.05 % | 22.23 % | 14.19 % |
Period | Shares Outstanding (M) | EPS (Riyal) | Adjusted EPS (Riyal) | Book Value (BV) |
---|---|---|---|---|
Q1 2013 | 44.85 | 2.39 | 2.39 | 18.19 |
Q2 2013 | 44.85 | 2.23 | 2.23 | 17.24 |
Q3 2013 | 44.85 | 2.17 | 2.17 | 17.65 |
Q4 2013 | 44.85 | 2.06 | 2.06 | 18.11 |
Q1 2014 | 44.85 | 2.09 | 2.09 | 17.28 |
Q2 2014 | 44.85 | 2.29 | 2.29 | 17.97 |
Q3 2014 | 44.85 | 2.33 | 2.33 | 18.46 |
Q4 2014 | 44.85 | 2.11 | 2.11 | 18.69 |
Q1 2015 | 44.85 | 2.00 | 2.00 | 19.26 |
Q2 2015 | 44.85 | 2.25 | 2.25 | 18.66 |
Q3 2015 | 44.85 | 2.36 | 2.36 | 19.22 |
Q4 2015 | 44.85 | 2.91 | 2.91 | 20.01 |
Q1 2016 | 44.85 | 3.03 | 3.03 | 20.60 |
Q2 2016 | 44.85 | 3.41 | 3.41 | 21.16 |
Q3 2016 | 44.85 | 3.46 | 3.46 | 21.75 |
Q4 2016 | 44.85 | 1.12 | 1.87 | 20.18 |
Q1 2017 | 44.85 | 0.73 | 1.48 | 20.51 |
Q2 2017 | 44.85 | (0.16) | 0.59 | 20.93 |
Q3 2017 | 44.85 | (0.17) | 0.58 | 21.52 |
Q4 2017 | 44.85 | 1.90 | 1.93 | 21.98 |
Q1 2018 | 44.85 | 2.13 | 2.15 | 22.38 |
Q2 2018 | 44.85 | 2.14 | 2.17 | 21.83 |
Q3 2018 | 44.85 | 1.80 | 1.82 | 22.09 |
Q4 2018 | 44.85 | 1.39 | 1.39 | 22.23 |
Q1 2019 | 44.85 | 1.48 | 1.48 | 22.90 |
Q2 2019 | 44.85 | 1.34 | 1.34 | 22.20 |
Q3 2019 | 44.85 | 1.46 | 1.46 | 22.57 |
Q4 2019 | 44.85 | 1.79 | 1.79 | 23.03 |
Q1 2020 | 44.85 | 1.86 | 1.86 | 23.77 |
Q2 2020 | 44.85 | 2.12 | 2.12 | 22.34 |
Q3 2020 | 44.85 | 2.12 | 2.12 | 22.71 |
Q4 2020 | 44.85 | 2.17 | 2.17 | 23.12 |
Q1 2021 | 44.85 | 2.23 | 2.23 | 23.92 |
Q2 2021 | 44.85 | 2.34 | 2.34 | 23.60 |
Q3 2021 | 44.85 | 2.71 | 2.71 | 24.34 |
Q4 2021 | 44.85 | 3.04 | 3.04 | 25.07 |
Q1 2022 | 44.85 | 2.91 | 2.91 | 25.74 |
Period | Shares Outstanding (M) | EPS (Riyal) | Adjusted EPS (Riyal) | Book Value (BV) |
---|---|---|---|---|
2012 | 44.85 | 2.34 | 2.34 | 13.60 |
2013 | 44.85 | 2.06 | 2.06 | 18.11 |
2014 | 44.85 | 2.13 | 2.13 | 18.69 |
2015 | 44.85 | 2.91 | 2.91 | 20.01 |
2016 | 44.85 | 1.12 | 1.87 | 20.18 |
2017 | 44.85 | 1.90 | 1.93 | 21.98 |
2018 | 44.85 | 1.39 | 1.39 | 22.23 |
2019 | 44.85 | 1.79 | 1.79 | 23.03 |
2020 | 44.85 | 2.17 | 2.17 | 23.12 |
2021 | 44.85 | 3.04 | 3.04 | 25.07 |
Period | P/E | Adjusted P/E | Price/book |
---|---|---|---|
Q1 2013 | 30.02 | 30.02 | 3.94 |
Q2 2013 | 26.07 | 26.07 | 3.37 |
Q3 2013 | 25.16 | 25.16 | 3.09 |
Q4 2013 | 26.43 | 26.43 | 3.01 |
Q1 2014 | 29.41 | 29.41 | 3.56 |
Q2 2014 | 32.48 | 32.48 | 4.14 |
Q3 2014 | 32.55 | 32.55 | 4.11 |
Q4 2014 | 26.03 | 26.03 | 2.94 |
Q1 2015 | 30.88 | 30.88 | 3.21 |
Q2 2015 | 28.44 | 28.44 | 3.44 |
Q3 2015 | 22.37 | 22.37 | 2.74 |
Q4 2015 | 19.04 | 19.04 | 2.77 |
Q1 2016 | 16.69 | 16.69 | 2.46 |
Q2 2016 | 18.71 | 18.71 | 3.02 |
Q3 2016 | 15.98 | 15.98 | 2.54 |
Q4 2016 | 58.81 | 35.19 | 3.27 |
Q1 2017 | 73.26 | 36.05 | 2.60 |
Q2 2017 | NEG | 79.11 | 2.25 |
Q3 2017 | NEG | 69.35 | 1.87 |
Q4 2017 | 22.90 | 22.57 | 1.98 |
Q1 2018 | 26.45 | 26.11 | 2.51 |
Q2 2018 | 27.67 | 27.32 | 2.72 |
Q3 2018 | 25.44 | 25.05 | 2.07 |
Q4 2018 | 36.28 | 36.28 | 2.26 |
Q1 2019 | 31.56 | 31.56 | 2.05 |
Q2 2019 | 43.34 | 43.34 | 2.62 |
Q3 2019 | 37.22 | 37.22 | 2.40 |
Q4 2019 | 27.22 | 27.22 | 2.11 |
Q1 2020 | 19.53 | 19.53 | 1.53 |
Q2 2020 | 19.83 | 19.83 | 1.88 |
Q3 2020 | 26.08 | 26.08 | 2.43 |
Q4 2020 | 24.62 | 24.62 | 2.31 |
Q1 2021 | 24.08 | 24.08 | 2.24 |
Q2 2021 | 29.10 | 29.10 | 2.88 |
Q3 2021 | 23.12 | 23.12 | 2.58 |
Q4 2021 | 20.59 | 20.59 | 2.50 |
Q1 2022 | 28.53 | 28.53 | 3.23 |
Period | P/E | Adjusted P/E | Price/book |
---|---|---|---|
2012 | - | - | - |
2013 | 26.43 | 26.43 | 3.01 |
2014 | 25.77 | 25.77 | 2.94 |
2015 | 19.04 | 19.04 | 2.77 |
2016 | 58.81 | 35.19 | 3.27 |
2017 | 22.90 | 22.57 | 1.98 |
2018 | 36.28 | 36.28 | 2.26 |
2019 | 27.22 | 27.22 | 2.11 |
2020 | 24.62 | 24.62 | 2.31 |
2021 | 20.59 | 20.59 | 2.50 |
Q1 2022
2022
Period | Medical Services | Pharmacies |
---|---|---|
Q1 2013 | 117.72 | 27.65 |
Q2 2013 | 115.21 | 26.98 |
Q3 2013 | 109.28 | 25.28 |
Q4 2013 | 134.04 | 30.12 |
Q1 2014 | 149.16 | 32.67 |
Q2 2014 | 149.31 | 30.43 |
Q3 2014 | 149.57 | 27.87 |
Q4 2014 | 161.93 | 33.06 |
Q1 2015 | 184.80 | 34.63 |
Q2 2015 | 196.41 | 31.45 |
Q3 2015 | 180.37 | 30.41 |
Q4 2015 | 191.80 | 28.80 |
Q1 2016 | 220.78 | 33.16 |
Q2 2016 | 230.14 | 29.62 |
Q3 2016 | 173.08 | 23.93 |
Q4 2016 | 162.66 | 27.28 |
Q1 2017 | 176.04 | 26.40 |
Q2 2017 | 190.13 | 26.41 |
Q3 2017 | 185.07 | 23.27 |
Q4 2017 | 202.08 | 25.76 |
Q1 2018 | 183.47 | 23.20 |
Q2 2018 | 175.85 | 23.20 |
Q3 2018 | 155.67 | 20.74 |
Q4 2018 | 154.94 | 26.74 |
Q1 2019 | 157.71 | 21.72 |
Q2 2019 | 149.87 | 20.07 |
Q3 2019 | 153.76 | 19.76 |
Q4 2019 | 162.79 | 22.72 |
Q1 2020 | 170.81 | 24.20 |
Q2 2020 | 164.47 | 21.52 |
Q3 2020 | 187.44 | 25.56 |
Q4 2020 | 192.76 | 22.19 |
Q1 2021 | 188.50 | 25.70 |
Q2 2021 | 178.18 | 24.30 |
Q3 2021 | 187.54 | 25.57 |
Q4 2021 | 188.78 | 26.82 |
Q1 2022 | 169.18 | 42.30 |
Period | Medical Services | Pharmacies |
---|---|---|
2012 | 418.98 | 105.76 |
2013 | 476.25 | 110.02 |
2014 | 609.97 | 124.03 |
2015 | 753.38 | 125.28 |
2016 | 786.66 | 113.99 |
2017 | 753.32 | 101.85 |
2018 | 669.93 | 93.87 |
2019 | 624.13 | 84.27 |
2020 | 715.48 | 93.47 |
2021 | 742.99 | 102.39 |
Item | Q1 2022 (e) | Q1 2022 (a) | Change |
---|---|---|---|
Average | 35.10 | 30.00 | (14.5 %) |
Item | Q1 2022 (e) | Q1 2022 (a) | Change |
---|---|---|---|
Al Rajhi Capital | 34.00 | 30.00 | (11.8) % |
AlJazira Capital | 36.20 | 30.00 | (17.1) % |
Current | |
Market Cap (M Riyal) | 9,355.71 |
Enterprise Value (EV) (M) | 9,052.72 |
Shares Outstanding ((M)) | 44.85 |
EPS ( Riyal) (TTM) | 5.93 |
Book Value (BV) ( Riyal) | 34.22 |
Par Value ( Riyal) | 10.00 |
Adjusted P/E (Last12) | 37.41 |
P/E (TTM) | 35.18 |
Price/book | 6.10 |
Return on Average Assets (%) (TTM) | 13.2 |
Return on Average Equity (%) (TTM) | 18.6 |
Argaam Investment Company has updated the Privacy Policy of its services and digital platforms. Know more about our Privacy Policy here.
Argaam uses cookies to personalize content, to provide social media features and analyze traffic, that we might also share with third parties. You consent to our cookies if you use this website
Comments {{getCommentCount()}}
Be the first to comment
رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}
{{comment.DisplayName}}
{{comment.ElapsedTime}}